Know the ropes: From basic science to corporate innovation
Investigating ways to cure disease, reduce mortality rates and improve life expectancy
R&D expenditure in the pharmaceutical industry is extremely high, yet some firms conduct unprofitable research while others do not. This study uncovers the determinants of private investment in basic science by linking the academic article database to corporations via author affiliation and funding acknowledgement. Its aim is to inform public policies that encourage businesses to invest and make technology advances in parts of the world where governments cannot, thereby helping relax resource constraints and assisting governments in basic infrastructure and services provision.